Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
1.570
-0.010 (-0.63%)
At close: Apr 28, 2026, 4:00 PM EDT
1.590
+0.020 (1.27%)
After-hours: Apr 28, 2026, 7:14 PM EDT
Aldeyra Therapeutics Market Cap
Aldeyra Therapeutics has a market cap or net worth of $94.49 million as of April 28, 2026. Its market cap has decreased by -16.23% in one year.
Market Cap
94.49M
Enterprise Value
40.58M
1-Year Change
-16.23%
Ranking
Category
Stock Price
$1.57
Market Cap Chart
Since May 2, 2014, Aldeyra Therapeutics's market cap has increased from $37.20M to $94.49M, an increase of 154.00%. That is a compound annual growth rate of 8.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 95.10M | -69.48% |
| Dec 31, 2025 | 311.60M | 4.85% |
| Dec 31, 2024 | 297.20M | 43.92% |
| Dec 29, 2023 | 206.50M | -49.34% |
| Dec 30, 2022 | 407.60M | 75.39% |
| Dec 31, 2021 | 232.40M | -12.73% |
| Dec 31, 2020 | 266.30M | 63.98% |
| Dec 31, 2019 | 162.40M | -25.44% |
| Dec 31, 2018 | 217.80M | 67.54% |
| Dec 29, 2017 | 130.00M | 93.16% |
| Dec 30, 2016 | 67.30M | 2.12% |
| Dec 31, 2015 | 65.90M | 63.93% |
| Dec 31, 2014 | 40.20M | 8.06% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oncolytics Biotech | 104.56M |
| Fractyl Health | 104.12M |
| Anixa Biosciences | 100.92M |
| Coya Therapeutics | 99.93M |
| NRx Pharmaceuticals | 97.45M |
| ProMIS Neurosciences | 97.30M |
| Inovio Pharmaceuticals | 94.23M |
| NeurAxis | 87.56M |